share_log

Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target

Benzinga ·  Dec 18 22:20  · Ratings

Maxim Group analyst Allen Klee reiterates HeartSciences (NASDAQ:HSCS) with a Buy and maintains $12 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment